Minimally Invasive Thoracic Surgery Intercostal Nerve Block Trial

Minimally Invasive Thoracic Surgery Intercostal Nerve Block Trial - Liposomal Bupivacaine Versus Standard Bupivacaine

The Minimally Invasive Thoracic Surgery Intercostal Nerve Block Trial is a single center, double-blind, randomized, active-comparator controlled clinical trial to assess the analgesic efficacy of intercostal nerve block by Liposomal Bupivacaine versus Standard Bupivacaine in subjects undergoing lung resection by robotic or video-assisted thoracoscopic surgery.

Inclusion Criteria:

• Robotic or Video-Assisted Lung Resection for All Indications

Exclusion Criteria:

• Additional Thoracic Procedures (beyond lung resection and mediastinal lymphadenectomy)
• Extra-Thoracic Procedures
• Hypersensitivity to Amide Local Analgesia
• Cardiac Conduction Abnormalities
• Hepatic Dysfunction
• Preoperative Neuropathic Pain and/or Preoperative Daily Opioid Usage